deltatrials
Unknown PHASE2 INTERVENTIONAL 1-arm NCT04789941

How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix

Phase II Trial To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix

Sponsor: Assiut University

Updated 4 times since 2021 Last updated: Mar 8, 2021 Started: Apr 1, 2021 Primary completion: Dec 30, 2021 Completion: Dec 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Locally Advanced Cervical Carcinoma and is currently ongoing. Assiut University leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Apr 2021 – ~Apr 2023 · 24 months · monthly snapshotNot Yet Recruiting~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown StatusUnknown

  3. Apr 2023 — Jul 2024 [monthly]

    Unknown Status PHASE2

    Status: Not Yet RecruitingUnknown Status

  4. Apr 2021 — Apr 2023 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Assiut University
Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.